61 / 74
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 29, No 6, November/December 2018
AFRICA
393
prediction of pre-eclampsia, placental abruption or delivery of a small for
gestational age baby.
Ultrasound Obstet Gynecol
1996;
7
: 182–188.
24. Albaiges G, Missfelder-Lobos H, Lees C, Parra M, Nicolaides KH. One
stage screening for pregnancy complications by clolour Doppler assess-
ment of the uterine arteries at 23 weeks gestation.
Obstet Gynecol
2000;
96
: 559–564.
25. Papageorghiou AT, Yu CK, Bindra R, Pandis G, Nicolaides KH.
Multicenre screening for pre-eclampsia and fetal growth restriction by
transvaginal uterine artery Doppler at 23 weeks gestation.
Ultrasound
Obstet Gynecol
2001;
18
: 441–449.
26. PoonLYC,AkolekarR,LachmannR,BetaJ,NicolaidesKH.Hyperetnsive
disorders in pregnancy:screening by biophysical and biochemical markers
at 11–13 week.
Ultrasound Obstet Gynecol
2010;
35
: 662–670.
27. Foidart J-M, Munaut C, Chantraine F, Akolekar R, Nicolaides KH.
Maternal plasma soluble endoglin at 11–13 weeks gestation in pre-
eclampsia.
Ultrasound Obstet Gynecol
2010;
35
: 680–687.
28. Brown MA, Lindheimer MD, de Swiet M, van Assche A, Moutquin
JM. The classification and diagnosis of the hypertensive disorders of
pregnancy: statement from the International Society for the Study of
Hypertension in Pregnancy (ISSHP).
Hypertens Pregnancy
2001;
20
:
IX–XIV.
29. Wright D, Akolekar R, Syngelaki A, Poon LC, Nicolaides KH. A
competing risks model in early screening for pre-eclampsia.
Fetal Diagn
Ther
2013;
32
: 171–178.
30. Verlohen S, Herraiz I, Lapaire O, Schlembach D, Ziesler H, Calda P,
et al
.
New gestational phase – specific cut-off values for the use of the soluble
fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic
test for pre-eclampsia.
Hypertension
2014;
63
: 346–352.
31. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal
vascular response to placentation in pregnancies complicated by pre-
eclampsia and small for gestational age infants.
Br J Obstet Gynecol
1986;
93
: 1049–1059.
32. Redman CW, Sargent Il. Placental debri, oxidative stress and pre-eclamp-
sia.
Placenta
2000;
21
: 597–602.
33. Eskild A, Romundstad PR, Vatten LJ. Placental weight and birthweight:
does the association differ between pregnancies with and without pre-
eclampsia.
Am J Obstet Gynecol
2009;
201
: 595. e1–5.
34. Poon LC, Kametas NA, Maiz N, Akolekar R, Nicolaides KH. First
trimester prediction of hypertensive disorders in pregnancy.
Hypertension
2009;
53
: 812–818.
35. Khalil A, Cowans NJ, Spencer K, Goichman S, Meiri H, Harrington K.
First trimester markers for the prediction of pre-eclampsia in women with
a priori high risk.
Ultrasound Obstet Gynecol
2010;
35
: 671–679.
36. Odegard RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R.
Pre-eclampsia and fetal growth.
Obstet Gynecol
2000;
96
: 950–955.
37. Mackay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from pre-
eclampsia and eclampsia.
Obstet Gynecol
2001;
97
: 533–538.
38. Moldenhaur JS, Stanek J, Warshak C, Khoury J, Sibai B. The frequency
and severity of placental findings in women with pre-eclampsia are gesta-
tional age dependent.
Am J Obstet Gynecol
2003;
189
: 1173–1177.
39. Espinoza J, Kusanovic JP, Bahado-Singh R, Gervasi MT, Romero R,
Lee W,
et al
. Should bilateral uterine artery notching be used in the risk
assessment for pre-eclampsia, small for gestational age , and gestational
hypertension?
J Ultrasound Med
2010;
29
: 1103–1115.
40. Waller DK, Lustig LS, Cunningham GC, Feuchtbaum LB, Hook EB.
The association between maternal serum alphafetoprotein and preterm
birth, small for gestational age foetuses, pre- eclampsia and placental
complications.
Obstet Gynecol
1996;
88
: 816–822.
41. Hund M, Schoedl M, Dilba P, Verhagen-Kamerbeek W, Stepan H.
Multicentre prospective clinical study to evaluate the prediction of
short term outcome in pregnant women with suspected pre-eclampsia
(PROGNOSIS): study protocol.
BMC Pregnancy Childbirth
2014;
14
:
324.
42. Rana S, Powe CE, Salahuddin S, Verlohren S, Kurumanchi SA.
Angiogenic factors and the risk of adverse outcomes in women with
suspected pre-eclampsia.
Circulation
2012;
125
; 911–919.
43. Verlohren S, Herraiz I, Lapaire O, Schlembach D. The s-Flt-1/PLGF ratio
in different types of hypertensive pregnancy disorders and its prognostic
potential in pre-eclamptic patients.
Am J Obstet Gynecol
2012;
20
6: 58.
e1–8.
44. Baschat AA, Genbruch U Weiner CP. Qualitative venous Doppler
waveforms analysis improves prediction of critical perinatal outcomes in
premature growth restricted foetuses.
Ultrasound Obstet Gynecol
2003;
22
: 240–245.
45. Turan OM, Turan S, Gungor S. Progression of Doppler anomalies in
intrauterine growth restriction.
Ultrasound Obstet Gynecol
2008;
32
:
160–167.
46. Meher S, Hernandez-Andrade E, Basheer SN, Lees C. Impact of cerebral
redistribution on neurodevelopmental outcome in small for gestational
age of growth restricted babies: a systematic review.
Ultrasound Obstet
Gynecol
2015;
46
: 398–404.
47. Kiserud T, Kessler J, Ebbing C. Ductus venosus shunting in growth
restricted foetuses and the effect of umbilical circulatory compromise.
Ultrasound Obstet Gynecol
2006;
28
: 143–149.
48. Baschat AA, Cosmi E, Bilardo CM. Predictors of neonatal outcome in
early onset placental dysfunction.
Obstet Gynecol
2007;
109
: 253–261.
49. Ferrazi E, Bozzo M, Rigano DS, Belloti M. Temporal sequence of abnor-
mal Doppler changes in the peripheral and central circulatory systems
of the severely growth restricted fetus.
Ultrasound Obstet Gynecol
2002;
19
: 140–146.
50. Bhorat IE, Bagratee J, Pillay M, Reddy T. Determination of the myocar-
dial performance index in deteriorating grades of intrauterine growth
restriction and its link to adverse outcomes.
Prenat Diagnosis
2014;
35
(3):
266–273.
51. Bhorat IE, Bagratee J, Reddy T. Assessment of fetal myocardial perfor-
mance in severe early onset pre-eclampsia (EO-PET) with and without
intrauterine growth restriction across deteriorating stages of placental
vascular resistance and links to adverse outcomes.
Eur J Obstet Gynaecol
Reprod Biol
2017:
210
: 325–333.
52. Soto E, Romero R, Kusanovic JP, Ogge G, Hussein Y, Yeo L,
et al
. Late
onset pre-eclampsia is associated with an imbalance of angiogenic and
anti-angiogenic factors in patients with and without placental lesions
consistent with maternal underperfusion.
J Matern Fetal Neonatal Med
2012;
25
: 498–507.
53. Roberge S, Nicolaides KH, Demers S, Villa P, Bujold E. Prevention of
perinatal death and adverse perinatal outcome using low dose aspirin: a
meta-analysis.
Ultrasound Obstet Gynecol
2013;
41
: 491–499.
54. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S,
et
al
. Prevention of pre-eclampsia and intrauterine growth restriction with
aspirin started early in pregnancy: a meta-analysis.
Obstet Gynecol
2010;
116
: 402–414.
55. Duley L, Hendersen-Smart DJ, Meher S, King JF. Antiplatelet agents for
preventing pre-eclampsia and its complications.
Cochrane Database Syst
Rev
2007; CD004659.
56. Pijnenborg R, Dixon G, Robertson WB, Brosens I. Trophoblastic inva-
sion of human decidua from 8-18 weeks of pregnancy.
Placenta
1980;
1
: 3–19.
57. Masotti G, Galanti G, Poggesi L, Abbate R, Neri Serneri GG. Differential
inhibition of prostacyclin production and platelet aggregation by aspirin.
Lancet
1979;
2
(8151): 1213–1217.